Skip to content
★ Sign in to follow
邓

邓学勤

Board Director
Director
科兴制药
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€472k
▼ Sales (0 ops.)
—

Latest filing published 30 May 2023 for 科兴制药, €60k.

Filing timeline

BuySale
邓学勤

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-15.3%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 30 May 2023 · 1258 days ago · €60k
    -7.6%
    Entry CN¥20.18 · Close at T+365 CN¥18.64
  • Filed 25 May 2023 · 1263 days ago · €117k
    -7.5%
    Entry CN¥20.57 · Close at T+365 CN¥19.02
  • Filed 23 May 2023 · 1265 days ago · €137k
    -4.7%
    Entry CN¥20.18 · Close at T+365 CN¥19.24
  • Filed 22 May 2023 · 1266 days ago · €130k
    -2.5%
    Entry CN¥20.41 · Close at T+365 CN¥19.89
  • Filed 17 May 2023 · 1271 days ago · €28k
    +1.4%
    Entry CN¥19.65 · Close at T+365 CN¥19.92

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

邓学勤: trading record in brief

邓学勤, listed as board member, appears in our data through filings on 科兴制药 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 17 May 2023 to 30 May 2023, the count stands at 5 filings.

Every open-market trade on record is a purchase: 5 purchases worth €472k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €117k. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -15.3%. This is a record of the past, not a forecast.

On 30 May 2023 came the latest disclosure, an open-market purchase for €60k in 科兴制药. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 邓学勤

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    董事Executives科兴制药
    452,733 CNY8SSE
    22,397 shares12.6% of flowA股XSHGSSE:173000006628061440
    Canonical exit: 28 Aug 2023 (T+90)
  • ▲
    董事Executives科兴制药
    886,735 CNY9SSE
    44,235 shares24.7% of flowA股XSHGSSE:173000006618638820
    Canonical exit: 23 Aug 2023 (T+90)
  • ▲
    董事Executives科兴制药
    1M CNY10SSE
    50,800 shares29.1% of flowA股XSHGSSE:173000006614201280
    Canonical exit: 21 Aug 2023 (T+90)
  • ▲
    董事Executives科兴制药
    992,500 CNY10SSE
    50,000 shares27.6% of flowA股XSHGSSE:173000006614257760
    Canonical exit: 20 Aug 2023 (T+90)
  • ▲
    董事Executives科兴制药
    214,315 CNY8SSE
    10,800 shares6.0% of flowA股XSHGSSE:173000006601808220
    Canonical exit: 15 Aug 2023 (T+90)

5 of 5 declarations